查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1475867

分子诊断试剂市场：依地区：2024-2031年全球产业分析、规模、占有率、成长、趋势、预测

Molecular Diagnostics Reagent Market by Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 258 Pages | 商品交期: 2-5个工作天内

价格
简介目录

该研究报告对全球分子诊断试剂市场进行了深入分析。这份综合报告提供了关键市场动态、成长动力、课题和新兴趋势的宝贵见解。它详细概述了医疗保健行业的分子诊断试剂领域，并提供了独家数据和统计数据来预测 2024 年至 2031 年的市场成长轨迹。

重要见解

  • 分子诊断试剂市场规模（2024年）：102.5亿美元
  • 预计市值（2031年）：140.2亿美元
  • 全球市场成长率（2024-2031年复合年增长率）：6.6%

分子诊断试剂市场 - 报告范围：

分子诊断试剂市场包括用于分子诊断测定的各种试剂、消耗品和检测试剂盒，用于检测和分析与疾病和遗传状况相关的核酸、蛋白质和其他生物标记。该市场针对临床实验室、医院、诊断中心和研究机构，包括聚合□链反应（PCR）、核酸扩增检测（NAAT）、原位杂交（ISH）和其他分子检测平台。分子诊断试剂在传染病诊断、肿瘤检测、基因筛检和个人化医疗中发挥重要作用，能够实现准确及时的诊断、预后预测和治疗监测。分子生物学、自动化技术、小型化技术的进步以及对精准医疗和伴随诊断不断增长的需求推动了市场成长。

市场驱动因素：

全球分子诊断试剂市场正受益于几个关键的成长促进因素。核酸扩增、定序和检测方法的技术进步正在彻底改变分子诊断，从而能够快速、灵敏地检测病原体、基因突变和疾病相关生物标记。此外，传染病、癌症和遗传性疾病的日益普及正在推动对用于疾病筛检、早期检测和治疗监测的分子诊断试剂的需求。此外，护理点分子检测平台、数位 PCR 系统和晶片实验室技术的采用正在扩大不同医疗机构（包括初级保健诊所、急诊室和资源有限的机构）对分子诊断的使用范围。此外，新型分子诊断检测方法和试剂的研发、监管审批和商业化的投资不断增加，刺激了市场成长和创新。

市场限制因素：

儘管分子诊断试剂市场成长前景广阔，仍面临监管监督、报销政策和市场片段化等课题。围绕分子诊断测试和试剂的监管环境（包括测定验证、品质控制和实验室认证要求）非常复杂，可能会对新进入者和创新技术的市场进入造成障碍。此外，来自医疗保健支付者和保险公司的报销变化和定价压力也会影响分子诊断产品和服务的市场推广和获利能力。此外，市场分散化以及来自免疫分析、即时检测和数位健康解决方案等替代诊断技术的竞争为市场整合和差异化带来了课题。为了解决这些障碍，行业利益相关者、监管机构和医疗保健提供者必须共同努力，简化监管途径，建立基于证据的报销政策，并加速分子诊断技术的采用。

市场机会：

由于技术创新、市场扩张和应用多样化，分子诊断试剂市场提供了巨大的成长机会。液体活检、循环肿瘤 DNA (ctDNA) 分析和无细胞核酸检测等新兴趋势为分子诊断试剂解决癌症诊断、治疗监测和微小残留疾病检测等未满足的需求提供了新途径。人工智慧 (AI)、机器学习 (ML) 和大数据分析的整合实现了分子诊断中数据驱动的决策、预测建模和精准医学方法。此外，策略合作伙伴关係、研究合作和併购使公司能够扩大其产品组合、扩大地理覆盖范围并利用新的市场趋势。对创新分子诊断测定和试剂的研发、临床验证和商业化的投资对于充分发挥分子诊断在个人化医疗中的潜力至关重要。

本报告解决的关键问题

  • 推动全球分子诊断试剂市场成长的因素有哪些？
  • 分子生物学和诊断技术的进步如何改变分子诊断试剂的竞争模式？
  • 分子诊断领域的市场进入者面临的主要课题和机会是什么？
  • 哪些疾病领域和诊断应用最有分子诊断试剂成长潜力？
  • 领先公司采取哪些策略来维持市场竞争力并推动创新？

目录

第一章 全球市场展望

  • 需求侧趋势
  • 供给面趋势
  • 分析与建议

第二章 市场概况

  • 市场范围/分类
  • 市场定义/范围/限制

第 3 章主要市场趋势

  • 影响市场的主要趋势
  • 产品创新/发展趋势

第 4 章 关键成功因素

  • 赎回场景
  • 产品映射
  • 监管场景

第五章全球分子诊断试剂市场-价格分析

  • 依产品类型划分的区域价格分析
  • 价格细目
    • 製造商级定价
    • 经销商级定价
  • 全球平均价格分析基准

第六章全球分子诊断试剂市场需求（数量与规模）分析

  • 过去的市场价值（金额）分析，2019-2023
  • 当前和未来市场价值（金额）预测，2024-2031
    • 同比增长趋势分析
    • 绝对回报机会分析

第七章市场背景

  • 宏观经济因素
  • 预测变量 - 相关性和影响
  • 价值链
  • 市场动态

第八章全球分子诊断试剂市场分析、产品类型

  • 简介/主要发现
  • 过去的市场规模（金额）和数量分析，2019-2023
  • 目前和未来的市场规模（金额）和定量分析/预测，2024-2031
    • 样品製备套件
    • PCR检测试剂盒
    • 原位杂交试剂盒
    • 微阵列晶片试剂盒
    • 定序试剂盒
  • 依产品类型分析市场吸引力

第九章全球分子诊断试剂市场分析（依应用）

  • 简介/主要发现
  • 过去的市场规模（金额）和数量分析，2019-2023
  • 目前和未来的市场规模（金额）和定量分析/预测，2024-2031
    • 病原体检测
    • 生物标记筛选
    • 治疗监测
    • 其他
  • 应用市场吸引力分析

第十章全球分子诊断试剂最终用户市场分析

  • 简介/主要发现
  • 过去的市场规模（金额）和数量分析，2019-2023
  • 目前和未来的市场规模（金额）和定量分析/预测，2024-2031
    • 医院
    • 研究所
    • 调查机构
    • 生物製药公司
    • 其他
  • 依最终用途划分的市场吸引力分析

第十一章全球分子诊断试剂市场分析（依地区）

  • 介绍
  • 过去的市场规模（金额）和数量分析，2019-2023
  • 当前市场规模（金额）和数量分析/预测，2024-2031
    • 北美
    • 拉丁美洲
    • 欧洲
    • 中东和非洲 (MEA)
    • 东亚
    • 南亚
    • 大洋洲
  • 区域市场吸引力分析

第十二章北美分子诊断试剂市场分析

第十三章拉丁美洲分子诊断试剂市场分析

第十四章欧洲分子诊断试剂市场分析

第十五章南亚分子诊断试剂市场分析

第十六章东亚分子诊断试剂市场分析

第十七章 大洋洲分子诊断试剂市场分析

第十八章中东及非洲分子诊断试剂市场分析

第十九章新兴国家分子诊断试剂市场分析

  • 全球和国家成长比较
  • 介绍
    • 主要国家市值占比分析
  • 中国分子诊断试剂市场分析
    • 介绍
    • 依市场类别划分的市值比率分析
    • 依市场类别分析和预测市场（数量/金额）
      • 产品类别
      • 依最终用途
      • 依申请
    • 中国分子诊断试剂市场-竞争格局
    • 中国贸易分析
  • 印度分子诊断试剂市场分析
    • 介绍
    • 依市场类别划分的市值比率分析
    • 依市场类别分析和预测市场（数量/金额）
      • 产品类别
      • 依最终用途
      • 依申请
    • 印度分子诊断试剂市场—竞争格局
  • 巴西分子诊断试剂市场分析
    • 介绍
    • 依市场类别划分的市值比率分析
    • 依市场类别分析和预测市场（数量/金额）
      • 产品类别
      • 依最终用户
      • 依申请
    • 巴西分子诊断试剂市场－竞争格局

第二十章市场结构分析

  • 依公司层级划分的市场分析（分子诊断试剂）
  • 市场集中度
  • 主要参与者的市场占有率分析
  • 市场存在分析

第 21 章 竞争分析

  • 比赛仪表板
  • 竞争价格分析
  • 衝突详情
    • F. Hoffmann-La Roche Ltd
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories Inc
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Agilent Technologies, Inc.
    • Qiagen NV
    • Illumina, Inc.
    • DiaSorin SpA
    • Hologic Inc.

第 22 章使用的假设和首字母缩略词

第23章研究方法论

简介目录
Product Code: PMRREP27472

Persistence Market Research, a prominent market research firm, has conducted an in-depth analysis of the global Molecular Diagnostics Reagent Market. This comprehensive report offers valuable insights into key market dynamics, growth drivers, challenges, and emerging trends. It provides a detailed overview of the molecular diagnostics reagent segment within the healthcare industry, presenting exclusive data and statistics projecting the market's growth trajectory from 2024 to 2031.

Key Insights:

  • Molecular Diagnostics Reagent Market Size (2024): USD10.25 Bn
  • Projected Market Value (2031): USD14.02 Bn
  • Global Market Growth Rate (CAGR 2024 to 2031): 6.6%

Molecular Diagnostics Reagent Market - Report Scope:

The Molecular Diagnostics Reagent Market encompasses a wide range of reagents, consumables, and test kits used in molecular diagnostic assays for the detection and analysis of nucleic acids, proteins, and other biomarkers associated with diseases and genetic conditions. This market serves clinical laboratories, hospitals, diagnostic centers, and research institutions, offering molecular reagents for polymerase chain reaction (PCR), nucleic acid amplification tests (NAATs), in situ hybridization (ISH), and other molecular testing platforms. Molecular diagnostics reagents play a critical role in infectious disease diagnostics, oncology testing, genetic screening, and personalized medicine, enabling accurate and timely diagnosis, prognosis, and treatment monitoring. Market growth is driven by advancements in molecular biology, automation, and miniaturization technologies, as well as increasing demand for precision medicine and companion diagnostics.

Market Growth Drivers:

The global Molecular Diagnostics Reagent Market benefits from several key growth drivers. Technological advancements in nucleic acid amplification, sequencing, and detection methods have revolutionized molecular diagnostics, enabling rapid and sensitive detection of pathogens, genetic mutations, and biomarkers associated with diseases. Moreover, the growing prevalence of infectious diseases, cancer, and genetic disorders drives demand for molecular diagnostics reagents for disease screening, early detection, and treatment monitoring. Additionally, the adoption of point-of-care molecular testing platforms, digital PCR systems, and lab-on-a-chip technologies expands access to molecular diagnostics in diverse healthcare settings, including primary care clinics, emergency departments, and resource-limited regions. Furthermore, increasing investment in research and development, regulatory approvals, and commercialization of novel molecular diagnostics assays and reagents stimulates market growth and innovation.

Market Restraints:

Despite its promising growth prospects, the Molecular Diagnostics Reagent Market faces challenges related to regulatory oversight, reimbursement policies, and market fragmentation. The complex regulatory landscape governing molecular diagnostics tests and reagents, including assay validation, quality control, and laboratory accreditation requirements, may pose barriers to market entry for new players and innovative technologies. Moreover, variability in reimbursement coverage and pricing pressures from healthcare payers and insurance providers impact market adoption and profitability for molecular diagnostics products and services. Additionally, market fragmentation and competition from alternative diagnostic technologies, such as immunoassays, point-of-care tests, and digital health solutions, create challenges for market consolidation and differentiation. Addressing these barriers requires collaboration between industry stakeholders, regulatory agencies, and healthcare providers to streamline regulatory pathways, establish evidence-based reimbursement policies, and promote technology adoption in molecular diagnostics.

Market Opportunities:

The Molecular Diagnostics Reagent Market presents significant growth opportunities driven by technology innovation, market expansion, and application diversification. Emerging trends such as liquid biopsy, circulating tumor DNA (ctDNA) analysis, and cell-free nucleic acid testing offer new avenues for molecular diagnostics reagents to address unmet needs in cancer diagnostics, treatment monitoring, and minimal residual disease detection. The integration of artificial intelligence (AI), machine learning (ML), and big data analytics enables data-driven decision-making, predictive modeling, and precision medicine approaches in molecular diagnostics. Furthermore, strategic partnerships, collaborations, and mergers and acquisitions enable companies to broaden their product portfolios, expand their geographic reach, and capitalize on emerging market trends. Investments in research and development, clinical validation, and commercialization of innovative molecular diagnostics assays and reagents are essential to harnessing the full potential of molecular diagnostics in personalized healthcare.

Key Questions Answered in the Report:

  • What factors are driving the growth of the Molecular Diagnostics Reagent Market globally?
  • How are advancements in molecular biology and diagnostic technologies reshaping the competitive landscape of molecular diagnostics reagents?
  • What are the key challenges and opportunities facing market participants in the molecular diagnostics segment?
  • Which disease areas and diagnostic applications offer the highest growth potential for molecular diagnostics reagents?
  • What strategies are leading companies employing to maintain their competitive edge and drive innovation in the market?

Competitive Intelligence and Business Strategy:

Leading players in the global Molecular Diagnostics Reagent Market, including biotechnology companies, diagnostic manufacturers, and healthcare suppliers, focus on innovation, product differentiation, and market expansion to gain a competitive edge. These companies invest in research and development to develop novel molecular diagnostics assays, reagents, and test kits tailored to specific disease indications and clinical workflows. Moreover, strategic collaborations with clinical laboratories, academic research institutions, and healthcare providers enable companies to validate product performance, demonstrate clinical utility, and accelerate market adoption. Furthermore, emphasis on customer support, technical training, and scientific education initiatives enhances brand reputation and customer loyalty in the competitive landscape of molecular diagnostics.

Key Companies Profiled:

  • F. Hoffmann-La Roche Ltd
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Agilent Technologies, Inc.
  • Qiagen N.V.
  • Illumina, Inc.
  • DiaSorin S.p.A
  • Hologic Inc.

Molecular Diagnostics Reagent Market Research Segmentation:

Molecular Diagnostics Reagent Market by Product

  • Sample Preparation Kits
  • PCR Assay Kits
  • In situ Hybridization Kits
  • Microarray Kit
  • Sequencing Kit

Molecular Diagnostics Reagent Market by Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa (MEA)

Table of Contents

1. Global Market Outlook

  • 1.1. Demand Side Trends
  • 1.2. Supply Side Trends
  • 1.3. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Reimbursement Scenario
  • 4.2. Product Mapping
  • 4.3. Regulatory Scenario

5. Global Molecular Diagnostic Reagent Market - Pricing Analysis

  • 5.1. Regional Pricing Analysis By Product Type
  • 5.2. Pricing Break-up
    • 5.2.1. Manufacturer Level Pricing
    • 5.2.2. Distributor Level Pricing
  • 5.3. Global Average Pricing Analysis Benchmark

6. Global Molecular Diagnostic reagent Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2031

  • 6.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 6.2. Current and Future Market Value (US$ Mn) Projections, 2024-2031
    • 6.2.1. Y-o-Y Growth Trend Analysis
    • 6.2.2. Absolute $ Opportunity Analysis

7. Market Background

  • 7.1. Macro-Economic Factors
    • 7.1.1. Global GDP Growth Outlook
    • 7.1.2. Global Internet Penetration Outlook
    • 7.1.3. Global Media and Entertainment Industry Outlook
  • 7.2. Forecast Factors - Relevance & Impact
    • 7.2.1. Top Companies Historical Growth
    • 7.2.2. Global IT Industry Outlook
    • 7.2.3. Global Urbanization Growth Outlook
    • 7.2.4. World Internet User Statistics
    • 7.2.5. Global e-Sports Industry Outlook
  • 7.3. Value Chain
  • 7.4. Market Dynamics
    • 7.4.1. Drivers
    • 7.4.2. Restraints
    • 7.4.3. Opportunity Analysis

8. Global Molecular Diagnostic reagent Market Analysis 2019-2023 and Forecast 2024-2031, by Product Type

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) and Volume Analysis By Product Type, 2019-2023
  • 8.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Product Type, 2024-2031
    • 8.3.1. Sample Preparation Kits
    • 8.3.2. PCR Assay Kits
    • 8.3.3. In situ Hybridization Kits
    • 8.3.4. Microarray Kit
    • 8.3.5. Sequencing Kit
  • 8.4. Market Attractiveness Analysis By Product Type

9. Global Molecular Diagnostic reagent Market Analysis 2019-2023 and Forecast 2024-2031, by Application

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) and Volume Analysis By Application, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Application, 2024-2031
    • 9.3.1. Pathogen Detection
    • 9.3.2. Biomarker Screening
    • 9.3.3. Therapeutic Monitoring
    • 9.3.4. Others
  • 9.4. Market Attractiveness Analysis By Application

10. Global Molecular Diagnostic reagent Market Analysis 2019-2023 and Forecast 2024-2031, by End User

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) and Volume Analysis By End Use, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By End Use, 2024-2031
    • 10.3.1. Hospitals
    • 10.3.2. Laboratories
    • 10.3.3. Research Institutes
    • 10.3.4. Biopharmaceutical Companies
    • 10.3.5. Others
  • 10.4. Market Attractiveness Analysis By End Use

11. Global Molecular Diagnostic reagent Market Analysis 2019-2023 and Forecast 2024-2031, by Region

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2019-2023
  • 11.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast By Region, 2024-2031
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. Middle East and Africa (MEA)
    • 11.3.5. East Asia
    • 11.3.6. South Asia
    • 11.3.7. Oceania
  • 11.4. Market Attractiveness Analysis By Region

12. North America Molecular Diagnostic reagent Market Analysis 2019-2023 and Forecast 2024-2031

  • 12.1. Introduction
  • 12.2. Pricing Analysis
  • 12.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 12.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 12.4.1. By Country
      • 12.4.1.1. U.S.
      • 12.4.1.2. Canada
    • 12.4.2. By Product Type
    • 12.4.3. By Application
    • 12.4.4. By End Use
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Country
    • 12.5.2. By Product Type
    • 12.5.3. By Application
    • 12.5.4. By End Use
  • 12.6. Market Trends
  • 12.7. Key Market Participants - Intensity Mapping
  • 12.8. Drivers and Restraints - Impact Analysis

13. Latin America Molecular Diagnostic reagent Market Analysis 2019-2023 and Forecast 2024-2031

  • 13.1. Introduction
  • 13.2. Pricing Analysis
  • 13.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 13.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 13.4.1. By Country
      • 13.4.1.1. Brazil
      • 13.4.1.2. Mexico
      • 13.4.1.3. Rest of Latin America
    • 13.4.2. By Product Type
    • 13.4.3. By Application
    • 13.4.4. By End Use
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Country
    • 13.5.2. By Product Type
    • 13.5.3. By Application
    • 13.5.4. By End User
  • 13.6. Market Trends
  • 13.7. Key Market Participants - Intensity Mapping
  • 13.8. Drivers and Restraints - Impact Analysis

14. Europe Molecular Diagnostic reagent Market Analysis 2019-2023 and Forecast 2024-2031

  • 14.1. Introduction
  • 14.2. Pricing Analysis
  • 14.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 14.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 14.4.1. By Country
      • 14.4.1.1. Germany
      • 14.4.1.2. Italy
      • 14.4.1.3. France
      • 14.4.1.4. U.K.
      • 14.4.1.5. Spain
      • 14.4.1.6. BENELUX
      • 14.4.1.7. Russia
      • 14.4.1.8. Rest of Europe
    • 14.4.2. By Product Type
    • 14.4.3. By Application
    • 14.4.4. By End Use
  • 14.5. Market Attractiveness Analysis
    • 14.5.1. By Country
    • 14.5.2. By Product Type
    • 14.5.3. By Application
    • 14.5.4. By End User
  • 14.6. Market Trends
  • 14.7. Key Market Participants - Intensity Mapping
  • 14.8. Drivers and Restraints - Impact Analysis

15. South Asia Molecular Diagnostic reagent Market Analysis 2019-2023 and Forecast 2024-2031

  • 15.1. Introduction
  • 15.2. Pricing Analysis
  • 15.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 15.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 15.4.1. By Country
      • 15.4.1.1. India
      • 15.4.1.2. Thailand
      • 15.4.1.3. Indonesia
      • 15.4.1.4. Malaysia
      • 15.4.1.5. Rest of South Asia
    • 15.4.2. By Product Type
    • 15.4.3. By Application
    • 15.4.4. By End User
  • 15.5. Market Attractiveness Analysis
    • 15.5.1. By Country
    • 15.5.2. By Product Type
    • 15.5.3. By Application
    • 15.5.4. By End User
  • 15.6. Market Trends
  • 15.7. Key Market Participants - Intensity Mapping
  • 15.8. 15.8.Drivers and Restraints - Impact Analysis

16. East Asia Molecular Diagnostic reagent Market Analysis 2019-2023 and Forecast 2024-2031

  • 16.1. Introduction
  • 16.2. Pricing Analysis
  • 16.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 16.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 16.4.1. By Country
      • 16.4.1.1. China
      • 16.4.1.2. Japan
      • 16.4.1.3. South Korea
    • 16.4.2. By Product Type
    • 16.4.3. By Application
    • 16.4.4. By End Use
  • 16.5. Market Attractiveness Analysis
    • 16.5.1. By Country
    • 16.5.2. By Product Type
    • 16.5.3. By Application
    • 16.5.4. By End User
  • 16.6. Market Trends
  • 16.7. Key Market Participants - Intensity Mapping
  • 16.8. Drivers and Restraints - Impact Analysis

17. Oceania Molecular Diagnostic reagent Market Analysis 2019-2023 and Forecast 2024-2031

  • 17.1. Introduction
  • 17.2. Pricing Analysis
  • 17.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 17.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 17.4.1. By Country
      • 17.4.1.1. Australia
      • 17.4.1.2. New Zealand
    • 17.4.2. By Product Type
    • 17.4.3. By Application
    • 17.4.4. By End User
  • 17.5. Market Attractiveness Analysis
    • 17.5.1. By Country
    • 17.5.2. By Product Type
    • 17.5.3. By Application
    • 17.5.4. By End User
  • 17.6. Market Trends
  • 17.7. Key Market Participants - Intensity Mapping
  • 17.8. Drivers and Restraints - Impact Analysis

18. Middle East and Africa Molecular Diagnostic reagent Market Analysis 2019-2023 and Forecast 2024-2031

  • 18.1. Introduction
  • 18.2. Pricing Analysis
  • 18.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 18.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 18.4.1. By Country
      • 18.4.1.1. GCC Countries
      • 18.4.1.2. Northern Africa
      • 18.4.1.3. South Africa
      • 18.4.1.4. Rest of Middle East and Africa
    • 18.4.2. By Product Type
    • 18.4.3. By Application
    • 18.4.4. By End Use
  • 18.5. Market Attractiveness Analysis
    • 18.5.1. By Country
    • 18.5.2. By Product Type
    • 18.5.3. By Application
    • 18.5.4. By End User
  • 18.6. Market Trends
  • 18.7. Key Market Participants - Intensity Mapping
  • 18.8. Drivers and Restraints - Impact Analysis

19. Emerging Countries Molecular Diagnostic reagent Market Analysis 2019-2023 and Forecast 2024-2031

  • 19.1. Global Vs. Country Growth Comparison
  • 19.2. Introduction
    • 19.2.1. Market Value Proportion Analysis, By Key Countries
  • 19.3. China Molecular Diagnostic reagent Market Analysis
    • 19.3.1. Introduction
    • 19.3.2. Market Value Proportion Analysis by Market Taxonomy
    • 19.3.3. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy
      • 19.3.3.1. By Product Type
      • 19.3.3.2. By End Use
      • 19.3.3.3. By Application
    • 19.3.4. China Molecular Diagnostic reagent Market - Competition Landscape
    • 19.3.5. China - Trade Analysis
  • 19.4. India Molecular Diagnostic reagent Market Analysis
    • 19.4.1. Introduction
    • 19.4.2. Market Value Proportion Analysis by Market Taxonomy
    • 19.4.3. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy
      • 19.4.3.1. By Product Type
      • 19.4.3.2. By End Use
      • 19.4.3.3. By Application
    • 19.4.4. India Molecular Diagnostic reagent Market - Competition Landscape
  • 19.5. Brazil Molecular Diagnostic reagent Market Analysis
    • 19.5.1. Introduction
    • 19.5.2. Market Value Proportion Analysis by Market Taxonomy
    • 19.5.3. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy
      • 19.5.3.1. By Product Type
      • 19.5.3.2. By End User
      • 19.5.3.3. By Application
    • 19.5.4. Brazil Molecular Diagnostic reagent Market - Competition Landscape

20. Market Structure Analysis

  • 20.1. Market Analysis by Tier of Companies (Molecular Diagnostic reagents)
  • 20.2. Market Concentration
  • 20.3. Market Share Analysis of Top Players
  • 20.4. Market Presence Analysis
    • 20.4.1. By Regional footprint of Players
    • 20.4.2. Product foot print by Players
    • 20.4.3. Channel Foot Print by Players

21. Competition Analysis

  • 21.1. Competition Dashboard
  • 21.2. Pricing Analysis by Competition
  • 21.3. Competition Deep Dive
    • 21.3.1. F. Hoffmann-La Roche Ltd
      • 21.3.1.1. Overview
      • 21.3.1.2. Product Portfolio
      • 21.3.1.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.1.4. Sales Footprint
      • 21.3.1.5. Strategy Overview
        • 21.3.1.5.1. Marketing Strategy
        • 21.3.1.5.2. Product Strategy
        • 21.3.1.5.3. Channel Strategy
    • 21.3.2. Becton, Dickinson and Company
      • 21.3.2.1. Overview
      • 21.3.2.2. Product Portfolio
      • 21.3.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.2.4. Sales Footprint
      • 21.3.2.5. Strategy Overview
        • 21.3.2.5.1. Marketing Strategy
        • 21.3.2.5.2. Product Strategy
        • 21.3.2.5.3. Channel Strategy
    • 21.3.3. Bio-Rad Laboratories Inc
      • 21.3.3.1. Overview
      • 21.3.3.2. Product Portfolio
      • 21.3.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.3.4. Sales Footprint
      • 21.3.3.5. Strategy Overview
        • 21.3.3.5.1. Marketing Strategy
        • 21.3.3.5.2. Product Strategy
        • 21.3.3.5.3. Channel Strategy
    • 21.3.4. Thermo Fisher Scientific Inc.
      • 21.3.4.1. Overview
      • 21.3.4.2. Product Portfolio
      • 21.3.4.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.4.4. Sales Footprint
      • 21.3.4.5. Strategy Overview
        • 21.3.4.5.1. Marketing Strategy
        • 21.3.4.5.2. Product Strategy
        • 21.3.4.5.3. Channel Strategy
    • 21.3.5. Merck KGaA
      • 21.3.5.1. Overview
      • 21.3.5.2. Product Portfolio
      • 21.3.5.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.5.4. Sales Footprint
      • 21.3.5.5. Strategy Overview
        • 21.3.5.5.1. Marketing Strategy
        • 21.3.5.5.2. Product Strategy
        • 21.3.5.5.3. Channel Strategy
    • 21.3.6. Agilent Technologies, Inc.
      • 21.3.6.1. Overview
      • 21.3.6.2. Product Portfolio
      • 21.3.6.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.6.4. Sales Footprint
      • 21.3.6.5. Strategy Overview
        • 21.3.6.5.1. Marketing Strategy
        • 21.3.6.5.2. Product Strategy
        • 21.3.6.5.3. Channel Strategy
    • 21.3.7. Qiagen N.V.
      • 21.3.7.1. Overview
      • 21.3.7.2. Product Portfolio
      • 21.3.7.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.7.4. Sales Footprint
      • 21.3.7.5. Strategy Overview
        • 21.3.7.5.1. Marketing Strategy
        • 21.3.7.5.2. Product Strategy
        • 21.3.7.5.3. Channel Strategy
    • 21.3.8. Illumina, Inc.
      • 21.3.8.1. Overview
      • 21.3.8.2. Product Portfolio
      • 21.3.8.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.8.4. Sales Footprint
      • 21.3.8.5. Strategy Overview
        • 21.3.8.5.1. Marketing Strategy
        • 21.3.8.5.2. Product Strategy
        • 21.3.8.5.3. Channel Strategy
    • 21.3.9. DiaSorin S.p.A
      • 21.3.9.1. Overview
      • 21.3.9.2. Product Portfolio
      • 21.3.9.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.9.4. Sales Footprint
      • 21.3.9.5. Strategy Overview
        • 21.3.9.5.1. Marketing Strategy
        • 21.3.9.5.2. Product Strategy
        • 21.3.9.5.3. Channel Strategy
    • 21.3.10. Hologic Inc.
      • 21.3.10.1. Overview
      • 21.3.10.2. Product Portfolio
      • 21.3.10.3. Profitability by Market Segments (Product/Channel/Region)
      • 21.3.10.4. Sales Footprint
      • 21.3.10.5. Strategy Overview
        • 21.3.10.5.1. Marketing Strategy
        • 21.3.10.5.2. Product Strategy
        • 21.3.10.5.3. Channel Strategy

22. Assumptions and Acronyms Used

23. Research Methodology